Picture of CSL logo

CSL CSL Income Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual income statement for CSL, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue8,5399,15110,31010,56213,310
Cost of Revenue
Gross Profit4,7775,2265,8435,7326,844
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses6,0356,4347,1807,63510,241
Operating Profit2,5042,7173,1302,9273,069
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes2,3412,5732,9632,7802,663
Provision for Income Taxes
Net Income After Taxes1,9192,1032,3752,2552,244
Minority Interest
Net Income Before Extraordinary Items
Net Income1,9192,1032,3752,2552,194
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income1,9192,1032,3752,2552,194
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS4.574.955.375.034.85
Dividends per Share